Supramolecular delivery of dinuclear ruthenium and osmium MCU inhibitors
Nicholas P. Bigham,Robyn J. Novorolsky,Keana R. Davis,Haipei Zou,Samantha N. MacMillan,Michael J. Stevenson,George S. Robertson,Justin J. Wilson
DOI: https://doi.org/10.1039/d4qi01102c
IF: 7.779
2024-07-13
Inorganic Chemistry Frontiers
Abstract:The transmembrane protein known as the mitochondrial calcium uniporter (MCU) mediates the influx of calcium ions (Ca 2+ ) into the mitochondrial matrix. An overload of mitochondrial Ca 2+ ( m Ca 2+ ) is directly linked to damaging effects in pathological conditions. Therefore, inhibitors of the MCU are important chemical biology tools and therapeutic agents. Here, two new analogues of previously reported Ru- and Os-based MCU inhibitors Ru265 and Os245, of the general formula [(C 10 H 15 CO 2 )M(NH 3 ) 4 (μ-N)M(NH 3 ) 4 (O 2 CC 10 H 15 )](CF 3 SO 3 ) 3 , where M = Ru ( 1 ) or Os ( 2 ), are reported. These analogues bear adamantane functional groups, which were installed to act as guests for the host molecule cucurbit-[7]-uril (CB[7]). These complexes were characterized and analyzed for their efficiency as guests for CB[7]. As shown through a variety of spectroscopic techniques, each adamantane ligand is encapsulated into one CB[7], affording a supramolecular complex of 1 : 2 stoichiometry. The biological effects of these compounds in the presence and absence of two equiv. CB[7] were assessed. Both complexes 1 and 2 exhibit enhanced cellular uptake compared to the parent compounds Ru265 and Os245, and their uptake is increased further in the presence of CB[7]. Compared to Ru265 and Os245, 1 and 2 are less potent as m Ca 2+ uptake inhibitors in permeabilized cell models. However, in intact cell systems, 1 and 2 inhibit the MCU at concentrations as low as 1 μM, marking an advantage over Ru265 and Os245 which require an order of magnitude higher doses for similar biological effects. The presence of CB[7] did not affect the inhibitory properties of 1 and 2 . Experiments in primary cortical neurons showed that 1 and 2 can elicit protective effects against oxygen-glucose deprivation at lower doses than those required for Ru265 or Os245. At low concentrations, the protective effects of 1 were modulated by CB[7], suggesting that supramolecular complex formation can play a role in these biological conditions. The in vivo biocompatibility of 1 was investigated in mice. The intraperitoneal administration of these compounds and their CB[7] complexes led to time-dependent induction of seizures with no protective effects elicited by CB[7]. This work demonstrates the potential for supramolecular interactions in the development of MCU inhibitors.
chemistry, inorganic & nuclear